LISA CLOUTIER: Open Payments
NPI 1164823332 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 28 payments from 12 companies in 2025. Trend: 2023 $599 · 2024 $1,188 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 6 | $152 |
| ABBVIE INC. | 4 | $85 |
| Janssen Pharmaceuticals, Inc | 2 | $68 |
| Almatica Pharma LLC | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| Lundbeck LLC | 3 | $62 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
Products named: FANAPT, VRAYLAR, REXULTI, INVEGA SUSTENNA, LOREEV XR, CAPLYTA, HETLIOZ, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
